Results
1 -
10 of
11Biricodar* shows promise in the treatment of patients with soft tissue sarcoma, Inpharma Weekly Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer, Cancer Chemotherapy and Pharmacology A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors, Journal of Molecular Modeling Overcoming drug resistance in ovarian carcinoma, Current Oncology Reports Reversal of ABC Transporter-Dependent Multidrug Resistance in Cancer, American Journal of Cancer Biricodar may overcome paclitaxel resistance, Inpharma Weekly